Traders assign a strong 92.5% implied probability to no new COVID variant of concern before 2027 because SARS-CoV-2 continues evolving mainly within established JN.1 lineages, with XFG currently dominating global sequences and driving updated 2026-2027 vaccines approved by the FDA in late August. Variants under monitoring such as NB.1.8.1 and BA.3.2 show immune escape but limited fitness advantages, preventing rapid displacement or escalation to higher-risk status. Declining genomic surveillance further reduces the chance of detecting a sudden, concerning shift in the near term, though ongoing circulation and potential compensatory mutations keep the door open for unexpected developments before the deadline.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于是
$245,310 交易量
$245,310 交易量
是
$245,310 交易量
$245,310 交易量
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
市场开放时间: Dec 1, 2025, 4:49 PM ET
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Traders assign a strong 92.5% implied probability to no new COVID variant of concern before 2027 because SARS-CoV-2 continues evolving mainly within established JN.1 lineages, with XFG currently dominating global sequences and driving updated 2026-2027 vaccines approved by the FDA in late August. Variants under monitoring such as NB.1.8.1 and BA.3.2 show immune escape but limited fitness advantages, preventing rapid displacement or escalation to higher-risk status. Declining genomic surveillance further reduces the chance of detecting a sudden, concerning shift in the near term, though ongoing circulation and potential compensatory mutations keep the door open for unexpected developments before the deadline.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于



警惕外部链接哦。
警惕外部链接哦。
常见问题